Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 21, 2017
What are the generic sources for epinephrine; lidocaine hydrochloride and what is the scope of epinephrine; lidocaine hydrochloride patent protection?
Epinephrine; lidocaine hydrochloride is the generic ingredient in nine branded drugs marketed by Intl Medication, Belmora Llc, Vyteris, West-ward Pharms Int, Astrazeneca, Carlisle, Bel Mar, Pharmaton, Iomed, Hospira, Septodont, Abbott, Eastman Kodak, Watson Labs, Dentsply Pharm, Empi, Fresenius Kabi Usa, and Dell Labs, and is included in thirty-one NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 9 |
| Patents: | 3 |
| Applicants: | 18 |
| NDAs: | 31 |
| Drug Master File Entries: see list | 19 |
| Suppliers / Packagers: see list | 11 |
| Clinical Trials: see list | 3,320 |
| Drug Prices: | see low prices |
| DailyMed Link: | epinephrine; lidocaine hydrochloride at DailyMed |
| Ingredient-type | Amides Catecholamines |
| Drug Class | Amide Local Anesthetic Antiarrhythmic alpha-Adrenergic Agonist beta-Adrenergic Agonist Catecholamine |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
| Physiological Effect | Local Anesthesia |
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | 6,862,473 | ► Subscribe | ||||||||||||||||||||||
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | 5,246,418 | ► Subscribe | ||||||||||||||||||||||
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | 6,377,847 | ► Subscribe | ||||||||||||||||||||||
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | 6,385,488 | ► Subscribe | ||||||||||||||||||||||
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | 5,873,850 | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Country | Document Number | Estimated Expiration | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia | 7310401 | ► Subscribe | |||||||||||||||||||||||||||
| Austria | 369891 | ► Subscribe | |||||||||||||||||||||||||||
| Japan | 2004501727 | ► Subscribe | |||||||||||||||||||||||||||
| European Patent Office | 1294439 | ► Subscribe | |||||||||||||||||||||||||||
| World Intellectual Property Organization (WIPO) | 0202182 | ► Subscribe | |||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,061 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
